Review

Kasa invaze olmayan mesane tümörlerinde BCG tedavisinin yeri
  • Hüsnü Tokgöz
  • Necmettin Aydın Mungan
Bull Urooncol 2010; 9: 14-21
BCG başarısızlığı ve ikincil tedaviler
  • Hakkı Perk
  • Sedat Yunusoğlu
Bull Urooncol 2009; 8: 15-20
BCG suşlarının tedavi edici etkinlik farkı var mı?
  • Hayrettin Şahin
Bull Urooncol 2011; 10: 18-20
İdame BCG kime uygulanmalı nasıl uygulanmalı?
  • Çetin Volkan Öztekin
  • Veli Erşahin
Bull Urooncol 2011; 10: 21-22
Is intravesical BCG treatment necessary and/or sufficient?
  • Sinan Ekici
  • Polat Türker
Bull Urooncol 2013; 12: 22-25
BCG komplikasyonları ve başa çıkma
  • Uğur Yücetaş
  • Gökhan Toktaş
Bull Urooncol 2011; 10: 23-25
Is it possible to predict BCG effectivity in the treatment of superficial bladder cancer? Are there any markers?
  • Polat Türker
  • Sinan Ekici
Bull Urooncol 2012; 11: 46-51
Role of Nanoparticles in the Treatment of Noninvasive Bladder Cancer
  • Erem Bilensoy
  • Nazlı Erdoğar
  • Aydın N. Mungan
Bull Urooncol 2015; 14: 61-66 DOI: 10.4274/uob.246
The Approach to High Risk Bladder Cancers in The Absence of Bacillus Calmette Guérin: What should Be the Treatment and Follow Up?
  • Polat Türker
  • Levent Türkeri
Bull Urooncol 2014; 13: 103-108 DOI: 10.4274/UOB.09

Review

Intravesical Therapies in Non-muscle Invasive Bladder Tumors
  • Serdar Geyik
Bull Urooncol 2019; 18: 24-29 DOI: 10.4274/uob.galenos.2018.1116

Case Report

A Rare Case of Granulomatous Hepatitis After Intravesical BCG Treatment
  • Erhan Erdoğan
  • Erçin Altıok
Bull Urooncol 2019; 18: 124-126 DOI: 10.4274/uob.galenos.2019.1183